| Market Cap | ₹1,502Cr |
| ROE | 10.52% |
| P/E Ratio(TTM) | 32.77 |
| EPS(TTM) | 14.51 |
| P/B Ratio | 3.09 |
| Dividend Yield | 0.21% |
| Industry P/E | 40.62 |
| Book Value | 154.00 |
| Debt to Equity | 0.49 |
| Face Value | 5 |
| Parent Organisation | Bajaj Healthcare |
| Managing Director | Mr. Anil Jain |
| NSE Symbol | BAJAJHCARE |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Cohance Lifesciences | NA (0.00%) | 87.58 | ||
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.40 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 32.46 | ||
| Wockhardt | NA (0.00%) | -139.73 |